|
|
|
| |
|
|
| From the Editor's Desk |
|
1-2 |
| Market Watch |
|
5-13 |
| |
New Funds |
|
|
| |
Investments |
|
|
| |
Exits |
|
|
| |
|
|
| VC Stories |
|
14-19 |
| |
A Hole-In-One Exit for ChrysCapital ( IVCJ Research) |
|
|
| |
Kshitij: Retail All The Way ( IVCJ Research) |
|
|
| |
Is SIDBI Heading for a Podium Finish (IVCJ Research) |
|
|
| |
|
|
| Sector Focus |
|
21-43 |
| |
Indian Lifesciences: Gathering Momemtum (IVCJ Research) |
|
|
| |
Introduction |
|
|
| |
Pharmaceutical: The Winds of Change |
|
|
| |
Indian Clinical Trials and Contact Research and Manufacturing |
|
|
| |
Biotechnology: The New Frontier |
|
|
| |
Healthcare: Poised to Scale New Heights |
|
|
| |
M&A's in Pharma in 2005 |
|
|
| |
Role of Venture Capital in the LifeSciences Sector |
|
|
| |
Sanjiv Kaul's 'Ten Commandments' (Sanjiv Kaul, ChrysCapital) |
|
47-51 |
| |
Indian Pharma Has Arrived (Nilesh Gupta, Lupin Ltd.) |
|
53-56 |
| |
Taking a Leap From Here… |
|
|
| |
...To Here |
|
|
| |
Role of Private Equity |
|
|
| |
Lupin |
|
|
| |
Conclusion |
|
|
| |
|
|
| Tax Angle |
|
57-67 |
| |
Indian Legal and Regulatory Environment — Indian Pharma Industry (Gowree Gokhale & Dr. Milind Antani - Nishith Desai Associates) |
|
|
| |
Indian Legal and Regulatory Environment — Indian Pharma Industry |
|
|
| |
Impact of TRIPS on the Indian Pharma Industry |
|
|
| |
Fiscal incentives available to commercial research and development companies |
|
|
| |
|
|
| Case Studies |
|
69-72 |
| |
Malladi Drugs & Pharmaceuticals Ltd. (IL&FS Investment Managers Ltd.) |
|
|
| |
Investor Profile |
|
|
| |
Investee Company Profile |
|
|
| |
What was the highlight of the deal structure |
|
|
| |
Valuation and Exit |
|
|
| |
What was the exit route and why? |
|
|
| |
Ranbaxy Fine Chemicals Ltd. (ICICI venture Funds Management Company Ltd.) |
|
|
| |
Background |
|
|
| |
Opportunity Identification |
|
|
| |
Transaction Execution |
|
|
| |
Value Enhancement by ICICI Venture |
|
|
| |
Thinking Ahead |
|
|
| |
Bharat Biotech International Ltd. (ICICI venture Funds Management Company Ltd.) |
|
|
| |
Background |
|
|
| |
Opportunity Identification |
|
|
| |
Transaction Execution |
|
|
| |
Current Status of the Company |
|
|
| |
Value Enhancement by ICICI Venture |
|
|
| |
|
|
| In Good Company |
|
74-79 |
| |
ChrysCapital Investment Advisors, India (IVCJ Research) |
|
|
| |
Company Profile |
|
|
| |
Management Team |
|
|
| |
Investment Philosophy |
|
|
| |
Investment Focus |
|
|
| |
Potential Investment Strutures |
|
|
| |
Investment Parameters |
|
|
| |
Value Addition Provided |
|
|
| |
Reasons for Success |
|
|
| |
Past and Present Investments |
|
|
| |
Interview with Mr. Sanjiv Kaul, Managing Director, Chryscapital |
|
|
| |
|
|
| Entrepreneurs' Corner |
|
80-81 |
| |
S. K. Handa of Claris Lifesciences (IVCJ Research) |
|
|
| |
|
|
| Globe Trotting |
|
82-84 |
| |
Inside the Term-Sheet Mindset of a LifeSciences VC (Arthur Klausner, AM Pappas & Associates) |
|
|
| |
Defining the Terms: Common, Options, and Preferred |
|
|
| |
And the Survey Says…. |
|
|
| |
Tricks of the VC Trade |
|
|
| |
Take-Home Message |
|
|
| |
|
|
| Learning Curve |
|
|
| |
Making it Trips Way - India's New Patent Regime (Rajkumar Dubey, Dubey & Partners) |
|
86-89 |
| |
Introduction |
|
|
| |
Historical Background of Patent Law in India |
|
|
| |
Conclusion |
|
|